April 23, 2009
NEWARK, Calif.--GE (NYSE:GE) announced today that it has signed a definitive agreement with SAFRAN for SAFRAN to acquire 81% of GE Security’s Homeland Protection business for $580MM. Upon close, GE will own 19% and SAFRAN will have majority interest with 81%. The transaction has been approved by the Boards of both companies, and will be [...]
Compact, Efficient 53-liter Incubator Optimizes Cell Growth
April 23, 2009
GREAT RIVER, NY. (April 23, 2009) -- The CB 53 Incubator from Binder Inc. offers a 1.9 cubic-foot capacity in a highly compact footprint to reduce operating costs and conserve valuable laboratory space. Hot-air chamber sterilization at 180° C makes this new addition to the BINDER CB family particularly well suited for applications in cell [...]
April 23, 2009
The GS FLX Titanium Series multi-span paired end kits and improved assembler software solidify 454 Sequencing System’s position as the technology of choice for de novo sequencing applications. BRANFORD, Conn.--454 Life Sciences, a Roche Company, announced today the launch of the new GS FLX Titanium Series Library Paired End Adaptors for improved whole genome de [...]
Novus Biologicals Opening First International Office in Cambridge, UK
April 23, 2009
Novus Biologicals, a Colorado based company supplying research reagents to the scientific community is opening its first international office in Cambridge, UK. The company is negotiating space in Cambridge Science Park, and has started the search for a divisional manager to head up the operation. Novus has worked with East of England International, a UK [...]
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
April 23, 2009
SAN DIEGO--SEQUENOM, Inc. (NASDAQ: SQNM) today announced that as a result of the continuing weak outlook in 2009 for capital equipment sales, particularly in the USA, the company has implemented cost cutting initiatives in the Genetic Analysis (GA) business to ensure the unit remains financially strong and approaches cash flow breakeven. These measures are expected [...]
Perlegen Out-Licenses Genetic Diagnostics Intellectual Property to Celera
April 23, 2009
Genetic Analysis Patents and Cardiac Genetic Markers Key to Development of New Celera Tests MOUNTAIN VIEW, Calif.--Perlegen Sciences, which develops genetic tests that correlate genetic variation to predisposition to disease and drug response, announced today that it has entered a non-exclusive license agreement with Celera focused on a family of patents that covers methods of [...]
Linguamatics Integrates ChemAxon Technology to Provide Enhanced Chemical Text Mining Capabilities
April 23, 2009
Chemical Structure Similarity and Substructure-Enabled Text Mining Available in I2E Platform New Capability on Show at Bio-IT World ‘09, Boston, April 27-29 Bio-IT World Conference & Expo ‘09 Linguamatics Booth no. 315 ChemAxon Booth no. 312 CAMBRIDGE, UK--Linguamatics, a leader in enterprise text mining for the life science and other markets, today announced a partnership [...]
Thermo Fisher Scientific Introduces New Solvent Recycling System
April 23, 2009
Thermo Scientific SRS Pro Reduces Mobile Phase Consumption by up to 90% MILFORD, MA., (23 April 2009) - Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Thermo Scientific SRS Pro Solvent Recycling System to re-use valuable solvent in light of the global acetonitrile shortage. With the ability to reduce mobile [...]
BioTek Instruments Relocates and Expands Singapore Office
April 23, 2009
April 23, 2009, WINOOSKI VT, USA — BioTek Instruments announced today the incorporation and expansion of BioTek Instruments Singapore, Pte. Ltd. This new and independent company will provide even greater support for the Asia Pacific distribution network and end-user customers. New office space includes conference suites and a demonstration facility for application optimization and training [...]
febit Receives European Patent for Gene Extraction Procedure
April 22, 2009
LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, April 22, 2009 – febit holding gmbh announced today, that the company has been granted the first European patent (EP1436609) for a microarray-based nucleic acid extraction procedure. In conjunction with the US patent US7320862, febit now holds a unique patent position in the dynamic market of sample preparation for [...]
